AEPCX
Price
$62.77
Change
+$0.52 (+0.84%)
Updated
Oct 3 closing price
Net Assets
138.77B
FIGRX
Price
$61.03
Change
+$0.57 (+0.94%)
Updated
Oct 3 closing price
Net Assets
11.82B
Interact to see
Advertisement

AEPCX vs FIGRX

Header iconAEPCX vs FIGRX Comparison
Open Charts AEPCX vs FIGRXBanner chart's image
American Funds EUPAC C
Price$62.77
Change+$0.52 (+0.84%)
VolumeN/A
Net Assets138.77B
Fidelity International Discovery
Price$61.03
Change+$0.57 (+0.94%)
VolumeN/A
Net Assets11.82B
AEPCX vs FIGRX Comparison Chart in %
View a ticker or compare two or three
VS
AEPCX vs. FIGRX commentary
Oct 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AEPCX is a Buy and FIGRX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
AEPCX has more cash in the bank: 139B vs. FIGRX (11.8B). FIGRX pays higher dividends than AEPCX: FIGRX (2.30) vs AEPCX (0.16). AEPCX was incepted earlier than FIGRX: AEPCX (25 years) vs FIGRX (39 years). AEPCX (1.57) is less costly to investors than FIGRX (0.58). FIGRX is a more actively managed with annual turnover of: 44.00 vs. AEPCX (35.00). FIGRX has a lower initial minimum investment than AEPCX: FIGRX (0) vs AEPCX (250). FIGRX annual gain was more profitable for investors over the last year : 21.56 vs. AEPCX (10.37). FIGRX return over 5 years is better than : 38.17 vs. AEPCX (13.86).
AEPCXFIGRXAEPCX / FIGRX
Total Expense Ratio1.570.58271%
Annual Report Gross Expense Ratio1.570.58271%
Fund Existence25 years39 years-
Gain YTD21.48227.38578%
Front LoadN/AN/A-
Min. Initial Investment2500-
Min. Initial Investment IRAN/AN/A-
Net Assets139B11.8B1,178%
Annual Yield % from dividends0.162.307%
Returns for 1 year10.3721.5648%
Returns for 3 years42.8272.3759%
Returns for 5 years13.8638.1736%
Returns for 10 years39.9566.6960%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TVRD40.232.86
+7.65%
Tvardi Therapeutics Inc
OACCU10.65N/A
N/A
Oaktree Acquisition Corp III Life Sciences
GNTA3.30-0.01
-0.25%
Genenta Science SpA
IMCR34.21-1.08
-3.06%
Immunocore Holdings plc
IDCC339.10-17.00
-4.77%
InterDigital